Spectral Medical Provides January Tigris Trial Update
Spectral Medical Inc. provided an update on the Company's Tigris trial, a Phase 3 follow-on study evaluating the use of Polymyxin B Hemoperfusion in a randomized controlled trial of adults treated...
Source: marketscreener.com